6533b7cffe1ef96bd125867b
RESEARCH PRODUCT
Comment on “ COVID ‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action”
Ayman AbdelmaksoudMichelangelo VestitaMichelangelo VestitaMohamad GoldustMohamad GoldustMohamad Goldustsubject
2019-20 coronavirus outbreakmedicine.medical_specialtyLetterCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralDermatologyBetacoronavirusPsoriasisMedicineHumansPsoriasisLimit (mathematics)LettersLetters to the EditorPandemicsLetter to the Editorbusiness.industrySARS-CoV-2COVID-19General Medicinemedicine.diseaseDermatologyAction (philosophy)businessCoronavirus InfectionsCoronavirus InfectionsImmunosuppressive Agentsyear | journal | country | edition | language |
---|---|---|---|---|
2020-04-16 | Dermatologic Therapy |